QUE ONCOLOGY
QUE Oncology, Inc. (QUE) was formed through a collaboration between Emory University, in Atlanta, Georgia, and The University of Queensland (UQ) research commercialization company, UniQuest, in Brisbane, Australia. QUE licenses intellectual property originating from research discoveries at both UQ and Emory’s Institute for Drug Development (EIDD). The leading drug candidate is Q-122, a compound with anti-inflammatory properties that is in Phase 1b clinical development for the treatment of hot flashes in women with breast cancer who are receiving anti-estrogen therapy. Additional cancer research projects that have been identified to supply the QUE Oncology pipeline are designed to address prostate cancer, breast cancer, melanoma, and cancer pain.
QUE ONCOLOGY
Industry:
Biopharma Biotechnology Health Care Therapeutics
Founded:
2012-01-01
Address:
Melbourne, Victoria, Australia
Country:
Australia
Website Url:
http://www.queoncology.com
Total Employee:
11+
Status:
Active
Total Funding:
16.52 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online Office 365 Mail Google Cloud
Current Employees Featured
Founder
Investors List
Uniseed Ventures
Uniseed Ventures investment in Series A - QUE Oncology
Stoic VC
Stoic VC investment in Series A - QUE Oncology
Brandon Capital Partners
Brandon Capital Partners investment in Series A - QUE Oncology
Georgia Research Alliance
Georgia Research Alliance investment in Grant - QUE Oncology
Georgia Research Alliance
Georgia Research Alliance investment in Grant - QUE Oncology
Georgia Research Alliance
Georgia Research Alliance investment in Grant - QUE Oncology
Georgia Research Alliance
Georgia Research Alliance investment in Grant - QUE Oncology
Georgia Research Alliance
Georgia Research Alliance investment in Grant - QUE Oncology
Georgia Research Alliance
Georgia Research Alliance investment in Grant - QUE Oncology
Official Site Inspections
http://www.queoncology.com Semrush global rank: 5.91 M Semrush visits lastest month: 1.4 K
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.171
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "QUE Oncology"
ABOUT QUE - queoncology
QUE Oncology is focused on unlocking the significant potential of its lead product Q-122 in development as a non-hormonal treatment for moderate to severe vasomotor symptoms (hot …See details»
Board of Directors - queoncology
Dennis Liotta, PhD . Over the past three decades Dr. Dennis Liotta’s research has focused on the discovery and development of novel antiviral, anticancer and anti-inflammatory therapeutic agents.See details»
QUE Oncology - Crunchbase Company Profile & Funding
QUE Oncology, Inc. (QUE) was formed through a collaboration between Emory University, in Atlanta, Georgia, and The University of Queensland (UQ) research commercialization …See details»
QUE Oncology - Uniseed
Website: www.queoncology.com QUE Oncology, Inc. (QUE) was formed in 2013 through a collaboration between Emory University’s Institute for Drug Development (EIDD), in Atlanta, Georgia, and the University of Queensland …See details»
QUE Oncology Company Profile 2024: Valuation, …
QUE Oncology General Information Description. Developer of novel non-hormonal therapies designed to address moderate to severe vasomotor symptoms. The company's orally bioavailable, non-hormonal, small molecule …See details»
QUE Oncology - Startup Galaxy
QUE Oncology, Inc. (QUE) was formed through a collaboration between Emory University, in Atlanta, Georgia, and The University of Queensland (UQ) research commercialization …See details»
QUE Oncology's non-hormonal therapy reduces hot flushes and …
MELBOURNE, Australia, Nov. 10, 2022 /PRNewswire/ -- QUE Oncology announces the results of its Phase II trial of Q-122, a novel non-hormonal oral therapy for the treatment of vasomotor …See details»
Que Oncology - Brandon BioCatalyst
QUE Oncology is a clinical stage company focussed on developing Q-122 for the treatment of hot flashes in cancer survivors undergoing endocrine therapy.See details»
Q-122 - queoncology
Q-122 is an orally bioavailable, non-hormonal, small molecule that is being developed by QUE Oncology as a treatment for vasomotor symptoms (VMS; also known as hot flashes and night …See details»
QUE Oncology - Craft
QUE Oncology is a company developing drugs to address medical needs associated with women's health conditions. It provides Q-122, an orally available small molecule for the …See details»
QUE Oncology Launches Phase II Trials in the United States
Apr 2, 2019 Women interested in further details about QUE Oncology’s clinical trials should visit www.queoncology.com. Notes to Editors: For further information or to arrange an interview, …See details»
QUE Oncology - Overview, News & Similar companies - ZoomInfo
Apr 2, 2019 QUE Oncology's non-hormonal therapy reduces hot flushes and night sweats in women with breast cancer, published in The Lancet MELBOURNE, Australia, Nov. 10, 2022 …See details»
Q-122 as a novel, non-hormonal, oral treatment for vasomotor
Nov 12, 2022 Background: Vasomotor symptoms (hot flushes and night sweats) are experienced by more than two-thirds of women with breast cancer taking oral adjuvant …See details»
OneOncology: Oncologist Network for Community-Based Cancer …
Data enabling care We are powered by an analytics platform that leverages clinical, operational, and financial data to enhance practice operations and enable our physicians to provide the …See details»
Advisors - queoncology
Professor Susan Davis AO, MBBS, FRACP, PhD, FAHMS . Prof Susan Davis AO, MBBS, FRACP PhD, FAHMS, is an NHMRC Senior Principal Research Fellow, Director, Monash University …See details»
Choose the Right Organizational Model for Oncology Practice
Jul 1, 2018 Baird says this part of the organization is essential to practice success. “The best way to optimize the model is to make sure you have the best possible information technology,” …See details»
Soins en oncologie: équipes Québec, traitements | FQC
The organization of care in oncology. The organization of care in oncology. Quebec launched a cancer control program (Programme de lutte contre le cancer) in 1998 following an extensive …See details»
THE TEAM | queoncology
© 2022 | QUE Oncology. bottom of pageSee details»
Oncology in Quebec - Fondation québécoise du cancer
The organization of care in oncology. Quebec launched a cancer control program (Programme de lutte contre le cancer) in 1998 following an extensive public and professional consultation. As …See details»